Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/05/2012CN101374843B Triazolopyridazines as tyrosine kinase modulators
09/05/2012CN101374503B Quickly disintegrating tablet produced by direct dry-tabletting
09/05/2012CN101370799B Cis-4, 5-biaryl-2-heterocyclic-imidazolines as MDM2 inhibitors
09/05/2012CN101367802B Beta-kabarin alkaloids in quassia wood, preparation method and application thereof
09/05/2012CN101365458B Methods and compositions for administration of iron
09/05/2012CN101362748B Method for preparing sertindole
09/05/2012CN101360752B Hiv integrase inhibitors
09/05/2012CN101360486B Nanoparticles for protein drug delivery
09/05/2012CN101357139B Multivitamin selenium-enriched active pearl oral preparation and preparation method thereof
09/05/2012CN101355876B Compositions for the eye adminstration
09/05/2012CN101342148B Quick-effective antimicrobial, anti-inflammation, antiviral hyperconcentrated natural allicin tablet and preparation method thereof
09/05/2012CN101340947B Combination of an iap-inhibitor and a taxane7
09/05/2012CN101336902B Liposomes sodium morrhuate
09/05/2012CN101336106B Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
09/05/2012CN101331950B Nutritional supplement for increasing sports break-out force
09/05/2012CN101331117B 5-lipoxygenase-activating protein (FLAP) inhibitors
09/05/2012CN101325882B Nutritional supplement containing long-chain polyunsaturated fatty acids
09/05/2012CN101322711B Health care medicament for resisting fatigue and enhancing immunity and preparation thereof
09/05/2012CN101321529B Diaryl aether derivant as antineoplastic agent
09/05/2012CN101304998B 7-substituted aza-indazoles, compositions containing same, production method and use thereof
09/05/2012CN101304743B Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
09/05/2012CN101300250B Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
09/05/2012CN101291909B Processes and intermediates
09/05/2012CN101284003B Medicinal composition containing andrographolide derivatives and preparation method thereof and application
09/05/2012CN101279970B 2-methyl-5-azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutied derivate, preparation and application thereof
09/05/2012CN101272779B Usage of phthalide derivant
09/05/2012CN101268070B Novel sulphonylpyrroles as inhibitors of HDAC novel sulphonylpyrroles
09/05/2012CN101267849B Porous coating loaded with a liquid or a solid substance
09/05/2012CN101265275B Diethyl 4-{6-[5-(2-chloro-6-methylanilinoformacyl)-thiazolyl-2-amino]-2-methylpyrimidin-4}-piperazin-1-phosphate
09/05/2012CN101248080B Inhibitors of VEGF receptor and HGF receptor signaling
09/05/2012CN101244048B Chalcone compounds and uses of the composition
09/05/2012CN101235020B Substituted cinnamamide derivatives and application of the same as nerve protecting agent
09/05/2012CN101203526B Process for preparing 3alpha(beta)-7alpha(beta)-dihydroxy-6alpha(beta)-alkyl-5beta-cholanic acid
09/05/2012CN101199523B Medicament composition containing levorotatory ammonia chlorine horizon and atorvastatin and preparing method thereof
09/05/2012CN101185653B Breviscapine oral administration composition and preparation method thereof
09/05/2012CN101180291B Benzimidazole-carboxamide compounds as 5-ht4, receptor agonists
09/05/2012CN101167799B Scutellaria barbata total flavone and its application in preparing influenza virus resisting medicine
09/05/2012CN101160291B Novel hsp90 inhibitor
09/05/2012CN101146526B Anti-microbial agent
09/05/2012CN101111475B Antiviral compounds and methods
09/05/2012CN101108197B Total polyoses from inula flower and use in regulating or treating diabetes and complication and immunoregulation
09/05/2012CN101098872B Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
09/05/2012CN101098691B Andrographolide derivatives to treat viral infections
09/05/2012CN101068815B Lactam compounds useful as protein kinase inhibitors
09/05/2012CN101031570B Inhibitors of VEGF receptor and HGF receptor signaling
09/05/2012CN101031307B Methods for inhibition of nkt cells
09/04/2012US8258328 Method and intermediates for preparing 19-norsteroid compounds
09/04/2012US8258316 Alkanoylamino benzamide aniline HDAC inhibitor compounds
09/04/2012US8258315 Process for forming amorphous atorvastatin
09/04/2012US8258311 Human protein tyrosine phosphatase inhibitors and methods of use
09/04/2012US8258309 Azapeptide derivatives
09/04/2012US8258308 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors
09/04/2012US8258307 Amide compound or salt thereof, and biofilm inhibitor, biofilm remover and disinfectant containing the same
09/04/2012US8258305 Dopamine transporter inhibitors for use in treatment of movement disorders and other CNS indications
09/04/2012US8258304 N-aryl piperidine substituted biphenylcarboxamides
09/04/2012US8258303 Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes
09/04/2012US8258302 Method for producing benzazepinone
09/04/2012US8258300 Azo dyes
09/04/2012US8258296 Crystalline antifungal compounds
09/04/2012US8258295 Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives
09/04/2012US8258294 Process for the preparation of temozolomide and analogs
09/04/2012US8258293 Tetrahydroquinoline derivatives
09/04/2012US8258290 Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from pseudomonas
09/04/2012US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
09/04/2012US8258272 20-O-beta-D-glucopyranosyl-20(S)-protopanaxatriol; apoptosis promoters, inhibitors; transcription factors; skin aging, cancer
09/04/2012US8258262 N-terminally chemically modified protein compositions and methods
09/04/2012US8258259 Macromolecular compounds having controlled stoichiometry
09/04/2012US8258255 Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
09/04/2012US8258188 Method of using punicic acid to enhance immune response and prevent metabolic disorders
09/04/2012US8258187 Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers
09/04/2012US8258186 Pharmaceutical for oral delivery comprising MGBG
09/04/2012US8258185 Use of neboglamine in the treatment of toxicodependency
09/04/2012US8258184 Use of vegetable butter-based cetyl myristoleate for treating osteoarthritis and other musculoskeletal disease conditions and injuries
09/04/2012US8258182 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
09/04/2012US8258181 Topically active agents to remove actinic keratoses and basal (BCC) and squamous (SCC) cell carcinomas using a combination of sulindac, its metabolites and derivatives with an oxidizing agent to generate reactive oxygen species nontoxic to normal cells; sulindac methionine sulfoxide/hydrogen peroxide
09/04/2012US8258180 Methods for making organozinc salts and compositions containing the same
09/04/2012US8258179 Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
09/04/2012US8258178 Agents for preventing attachment of barnacle consisting of organic solvent extracts of red alga Laurencia sp. and compounds isolated therefrom
09/04/2012US8258177 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
09/04/2012US8258176 Dithiolopyrrolone compounds, the preparation and the use thereof
09/04/2012US8258175 Isoindolin-1-one derivatives
09/04/2012US8258173 Melatonin derivatives and their use as antioxidants
09/04/2012US8258172 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
09/04/2012US8258171 pH-sensitive fluorescent probe
09/04/2012US8258170 Inhibitors of plasma kallikrein
09/04/2012US8258169 Pyrazole-4-N-alkoxycarboxamides as microbiocides
09/04/2012US8258168 2H or 3H-benzo[E]indazol-1-YL carbamate derivatives, the preparation and therapeutic use thereof
09/04/2012US8258166 Pharmaceutical composition
09/04/2012US8258165 Pharmaceutical composition
09/04/2012US8258164 treating microbial infections with aqueous composition free of crystals of metronidazole, tinidazole; inhibiting the crystallization by adding citric acid; dermatologic skin disorders such as rosacea, acne, and dermatitis
09/04/2012US8258163 Small-molecule agonists for type-2 orexin receptor
09/04/2012US8258162 Catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
09/04/2012US8258161 Crystalline salt form of an antidiabetic compound
09/04/2012US8258160 SCD1 inhibitors triazole and tetrazole compounds
09/04/2012US8258159 Inhibitors of the α2β1/GPIa-IIa integrin
09/04/2012US8258158 HSL inhibitors useful in the treatment of diabetes
09/04/2012US8258156 Compounds and compositions as modulators of GPR119 activity
09/04/2012US8258155 Quinine sulfate/bisulfate solid complex; methods of making; and methods of use thereof
09/04/2012US8258154 Bicyclic heteroaryl inhibitors of PDE4
09/04/2012US8258153 Methods, compositions, and kits for the treatment of ophthalmic disorders
1 ... 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 ... 7860